Home Neurelis

Neurelis

In operation
Series D
Producer of Drug Candidates for Epilepsy and Central Nervous System Disorders
Basic
Enterprise Profile

Basic Information

Neurelis is a specialized pharmaceutical company that licenses, develops, and commercializes drug candidates for the epilepsy and central nervous system (CNS) markets.Specialized pharmaceutical company Neurelis licenses, develops, and commercializes product candidates for the epilepsy and broader central nervous system (CNS) market.
Neurelis, Inc.
SanDiego,California,United States of America
15~50 people
January 01, 2007
cchambliss@neurelis.com

Enterprise Profile

Industrial Sector
New Drug Development Production of Pharmaceutical Intermediates
Technology
Biotechnology
Concept
# Nervous System Diseases Therapeutic Products
Application Scenarios
Innovative Drugs